Beth Reinhard @bethreinhard
Emergent is the only maker of multiple drugs the government deems crucial for the Strategic National Stockpile, and the government is the company’s primary customer...annual revenue rose from $235 million in 2009 to $1.1 billion a decade later, much of it in no-bid contracts. — PolitiTweet.org
Beth Reinhard @bethreinhard
How to become highest-paid, most important contractor to HHS office in charge of national stockpile: no-bid contrac… https://t.co/CUklAHcvbj
